For the quarter ending 2026-03-31, KZR has $67,999K in assets. $2,762K in debts. $66,229K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|
| Marketable securities | - | 51,281 | 66,482 | |
| Cash and cash equivalents | 66,229 | 38,935 | 34,367 | |
| Prepaid expenses and other current assets | 1,334 | 4,285 | 3,853 | |
| Assets held for sale | 0 | - | - | |
| Total current assets | 67,563 | 94,501 | 104,702 | |
| Other assets | - | 0 | 674 | |
| Property and equipment, net | 0 | 2,175 | 2,407 | |
| Operating lease right-of-use asset | 436 | 1,050 | 1,340 | |
| Total assets | 67,999 | 97,726 | 109,123 | |
| Debt, current | - | 5,279 | 5,293 | |
| Accounts payable | 273 | 911 | 1,157 | |
| Accrued and other current liabilities | 1,135 | 3,927 | 4,107 | |
| Operating lease liabilities, current | 1,354 | 3,259 | 3,808 | |
| Total current liabilities | 2,762 | 13,376 | 14,365 | |
| Operating lease liabilities, noncurrent | - | 0 | 344 | |
| Debt, noncurrent | - | 1,374 | 2,628 | |
| Total liabilities | 2,762 | 14,750 | 17,337 | |
| Common stock, 0.001 par value, 250,000,000 shares authorized as of march31, 2026 (unaudited) and december31, 2025 7,374,375 and 7,331,739 shares issued and outstanding as of march31, 2026 (unaudited) and december31, 2025, respectively | 7 | 7 | 7 | |
| Additional paid-in capital | 561,518 | 558,941 | 556,805 | |
| Accumulated other comprehensive income (loss) | 0 | 14 | -267 | |
| Accumulated deficit | -496,288 | -475,986 | -464,759 | |
| Total stockholders' equity | 65,237 | 82,976 | 91,786 | |
| Total liabilities and stockholders' equity | 67,999 | 97,726 | 109,123 | |
Kezar Life Sciences, Inc. (KZR)
Kezar Life Sciences, Inc. (KZR)